维普中文期刊产品整合服务
34篇 您的检索式:作者名="Chervinsky P"
    题名 作者 年代 出处 被引量
1Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial显示文摘Reiss TF Chervinsky P Dockhorn R J 1998Arch Intern Med1998,158,11:1
2Placebo-con-trolled, comparative study of the efficacy and safety of tri-amcinolone acetonide inhalation aerosol with the non-CFC propeUant HFA-134a in patients with asthma显示文摘Jacobson K Chervinsky P Noonan M 1999Ann Ann Aller-gy Asthma Immunol1999,83,1:1
3Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma显示文摘Busse WW Chervinsky P Condemi J 1998J Allergy Clin Immunol1998,101,41:1
4Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma, a multieenter, randomized, double blind trial 显示文摘Reiss TF Chervinsky P Shingo S 1998Areh lmem Med1998,158,:1
5A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal aller-gic rhinitis with mometasoue furoate aqueous nasal spray 显示文摘Graft D Aaronson D Chervinsky P 1996JAllergy Clin Immunol1996,98,4:1
6显示文摘Reiss TF Chervinsky P Dockhorn RJ 1998Arch Intern Med1998,158,11:1
7Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis显示文摘Chervinsky P Casale T Townley R 2003Ann Allergy Asthma Immunol2003,91,:1
8IgG subtype abnormalities with normal total IgG in a clinical allergy practice显示文摘Noyes J Woodmansee D Chervinsky P 1986Ann Allergy1986,57,4:1
9Omalizumab,an anti-IgE antibody,in the treatment of adults and adolescents with perennial allergic rhinitis显示文摘CHERVINSKY P CASALE T TOWNLEY R 2003Ann Allergy Asthma Immunol2003,91,:1
10Flutikasone,propinate powder and lack of clincally significant effects on hypothalamic-pituitary-adrenai axis and bone mineral density over 2 years in adults with mild asthma显示文摘Li JT Ford LB Chervinsky P 0,,6:1
11IgG subtype abnormalities with normal total IgG in a clinical allergy practice 显示文摘Noyes J Woodmansec D Chervinsky P 1986Ann Allergy1986,57,4:1
12Efficacy and safety of doxofyl- line compared to theophylline in chronic reversible asthma-a double blind, randomized, placebo controlled-muhicentre clinical trial显示文摘Goldstein MF Chervinsky P 2002Med Sci Monit2002,8,:1
13IgG subtype abnormalities with normal total IgG in a clinical allergy practice显示文摘Noyes J Woodmansee D Chervinsky P 0,,:1
14Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma-a double-blind randomized placebo-controlled multicentre clinical trial显示文摘Goldstein MF Chervinsky P 2002Med Sci Monit2002,8,4:1
15Performance of four age groups of normal elderly on the Rey Auditory-Verbal Learning Test 显示文摘Mitrushina M Satz P Chervinsky A 1991J Clin Psychol1991,47,3:1
16Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma--a double-blind randomized placebo-controlled multicentre clinical trial 显示文摘GOLDSTEIN M F CHERVINSKY P 2002Med Sci Monit2002,8,4:1
17Fluticasone propionate powder and lack of clinically significant effects on hypo - thalamic - pituitary - adrenal axis and bone mineral density over 2 years in aduls with mild asthma显示文摘Li JT Ford LB Chervinsky P et at 1999J Allergy clin Immunol1999,103,6:1
18A placebo-and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with monetasone furoate aqueous nasal spray显示文摘GRAFT D AARONSON D CHERVINSKY P 1996J Allergy Clin lmmunol1996,98,:1
19A comparison of salmeterol with abuterol in the treatment of mild-to-moderate asthma显示文摘Pealman DS Chervinsky P LaForce C 1992N Engl J Med1992,327,:1
20Montelukast, a once- daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double - blind trial montelukast clinical research study group 显示文摘Reiss TF Chervinsky P Dockhorn RJ 1998Arch Intern Med1998,158,11:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费